Androgen receptor modulators and methods for their use
US11059795B2 · kind B2 · utility
8Cited by
30References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 20, 2020 |
| Grant date | Jul 13, 2021 |
| Priority date | — |
| Expiry date | Apr 20, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D307/64
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I)-(VI) and/or (A)-(H-I), or any subgenera thereof, or a pharmaceutically acceptable salt, tautomer or stereoisomer. The compounds of the present disclosure are useful in modulating androgen receptor activity and for treating cancer including prostate cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.